Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2

Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: شاهین حلاج , آناهیتا قربانی , سید علی موسوی اقدس , محمد میرزا آقازاده عطاری , فرهاد جدیدی نیارق

کلمات کلیدی: Angiotensin-converting enzyme, ACE, COVID, Coronavirus, Immunology, RAS

نشریه: 14521 , 1 , 1 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فرهاد جدیدی نیارق
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 73389
عنوان فارسی مقاله Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2
عنوان لاتین مقاله Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

The coronavirus disease 2019 (COVID-19) pandemic has affected the daily lives of millions of people worldwide and had caused significant mortality; hence the assessment of therapeutic options is of great interest. The leading cause of death among COVID-19 patients is acute respiratory distress syndrome caused by hyper inflammation secondary to cytokine release syndrome (CRS). Cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, interferon (IFN)-γ, and IL-10, are the main mediators of CRS. Based on recent evidence, the angiotensin-converting enzyme (ACE) II is known to be the target of the COVID-19 spike protein, which enables the virus to penetrate human cells. ACE II also possesses an anti-inflammatory role in many pathologies such as CVD (Cardiovascular Disease), HTN (Hypertension), DM (Diabetes Mellitus), and other conditions, which are the main risk factors of poor prognosis in COVID-19 infection. Changes in tissue ACE II levels are associated with many diseases and hyperinflammatory states, and it is assumed that elevated levels of ACE II could aggravate the course of COVID-19 infection. Therefore, the use of Renin-Angiotensin, Aldosterone System Inhibitors (RASi) in COVID-19 patients could be hypothetically considered, though sufficient evidence is not presented by the scientific community. In the present manuscript, based on the most recent pieces of evidence, the roles of RAS and RASi in immunologic interactions are addressed. Furthermore, the molecular and immunologic aspects of RASi and their potential significance in COVID-19 is discussed.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
شاهین حلاجاول
آناهیتا قربانیدوم
سید علی موسوی اقدسسوم
محمد میرزا آقازاده عطاریچهارم
فرهاد جدیدی نیارقهشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2.pdf1399/07/124312294دانلود